School of Pharmaceutical Sciences, Zhengzhou University, 100 Science Road, Zhengzhou, 450001, People's Republic of China.
Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, 100 Science Road, Zhengzhou, 450001, Henan Province, People's Republic of China.
J Nanobiotechnology. 2022 May 2;20(1):209. doi: 10.1186/s12951-022-01406-9.
Multidrug resistance is still a major obstacle to cancer treatment. The most studies are to inhibit the activity of the drug transporter P-glycoprotein (P-gp), but the effect is not ideal. Herein, a nanosystem was built based on cascade catalytic consumption of cholesterol. Cholesterol oxidase (natural enzyme, COD) was immobilized on the carrier (NH-MIL-88B, MOF) through amide reaction, COD catalyzed the consumption of cholesterol, the reaction product HO was further produced by the MOF with its peroxidase-like activity to produce hydroxyl radicals (•OH) with killing effect. Due to the high expression of CD44 receptor on the surface of tumor cells, we encapsulated chondroitin sulfate gel shell (CS-shell) with CD44 targeting and apoptosis promoting effect on the surface of DOX@MOF-COD nanoparticles, which can accurately and efficiently deliver the drugs to the tumor site and improve the effect of reversing drug resistance. Taking drug-resistant cell membrane as "breakthrough", this paper will provide a new idea for reversing multidrug resistance of tumor.
多药耐药性仍然是癌症治疗的主要障碍。大多数研究旨在抑制药物转运蛋白 P-糖蛋白 (P-gp) 的活性,但效果并不理想。在此,构建了基于胆固醇级联催化消耗的纳米系统。胆固醇氧化酶(天然酶,COD)通过酰胺反应固定在载体(NH-MIL-88B,MOF)上,COD 催化胆固醇的消耗,反应产物 HO 进一步由 MOF 具有过氧化物酶样活性产生具有杀伤作用的羟基自由基(•OH)。由于肿瘤细胞表面高表达 CD44 受体,我们在 DOX@MOF-COD 纳米粒表面包被了具有 CD44 靶向和促进细胞凋亡作用的硫酸软骨素凝胶壳(CS-壳),可以准确高效地将药物递送到肿瘤部位,提高逆转耐药的效果。以耐药细胞膜为“突破口”,为肿瘤多药耐药性的逆转提供了新的思路。